feed,title,long_url,short_url
MedRxiv,in silico Assessment of Antibody Drug Resistance to Bamlanivimab of SARS-CoV-2 Variant B.1.617,https://biorxiv.org/cgi/content/short/2021.05.12.443826v1?rss=1,https://j.mp/3tMxWCg
